The goals of this Funding Opportunity Announcement (FOA) are to stimulate further research on delineating the pathophysiology of HIV-1 associated CNS disease in the setting of chronic viral suppression and ART. In addition, FOA also encourages research studies to aid in the identification/ validation of biomarkers and pre-clinical targets with quantifiable readouts in domestic and international settings. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system (CNS) in the context of viral suppression. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required

Notice Special Interest NOSI): Development Preliminary Testing Health-related Behavioral Interventions Notice Number: NOT-OD-20-106 Key Dates Release Date: 19, 2020 First Available Due Date: July 23, 2020 Expiration Date: September 26, 2022 Related Announcements PAR-19-213 - Behavioral & Integrative Treatment Development Program R34 Clinical Trial Optional) PAR-19-212 - Behavioral & Integrative Treatment Development Program R01 Clinical Trial Optional) PA-18-849 - Prevention Research Mid-Life Adults R01 Clinical Trial Optional) PA-18-850 - Prevention Research Mid-Life Adults R21 Cli

Notice Special Interest: Secondary Analyses Existing Alcohol Research Data Notice Number: NOT-AA-20-018 Key Dates Release Date: August 10, 2020 First Available Due Date: October 05, 2020 Expiration Date: September 05, 2023 Related Announcements PA-20-185 - NIH Research Project Grant Parent R01 Clinical Trial Allowed) PA-20-200 - NIH Small Research Grant Program Parent R03 Clinical Trial Allowed) PA-20-195- NIH Exploratory/Developmental Research Grant Program Parent R21 Clinical Trial Allowed) Issued National Institute Alcohol Abuse Alcoholism NIAAA) Purpose purpose this Notice Sp

This Funding Opportunity Announcement (FOA) entitled "Innovative Research in Cancer Nanotechnology (IRCN)" encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize mechanistic studies toward fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems.

The purpose of this funding opportunity announcement (FOA) is to support research on interventions to improve health in Native American (NA) populations.

The purpose of this Funding Opportunity Announcement (FOA) is to support multidisciplinary research teams with complementary expertise in HIV and pathobiology, pathophysiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will comprehensively interrogate fundamental mechanisms underlying HIV-associated comorbidities, coinfections, and complications relevant to the mission of the NIDDK and advance progress toward alleviating them.

The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services.

The purpose of this Funding Opportunity Announcement (FOA) is to support multidisciplinary research teams with complementary expertise in HIV and physiology, pathophysiology, pathobiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

The purpose of this Funding Opportunity Announcement (FOA) is to understand the contribution of specific elements of maternal molecular and cellular factors that can control and effect the development of the fetal immune system.